FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anatoly Langer

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

Canada

Procedures

Co-author Network

Publications

TOP 3
Sammy Ali; Shaun G Goodman; Raymond T Yan; Andrzej Budaj; Keith A A Fox; Joel M Gore; David Brieger; Jose López-Sendón; Anatoly Langer; Frans Van de Werf; Ph Gabriel Steg; Andrew T Yan
Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes.
Pamela M Katz; Aurora A Mendelsohn; Shaun G Goodman; Anatoly Langer; Hwee Teoh; Lawrence A Leiter
Use of a treatment optimization algorithm involving statin-ezetimibe combination aids in achievement of guideline-based low-density lipoprotein targets in patients with dyslipidemia at high vascular risk Guideline-based Undertaking to Improve Dyslipidemia Management in Canada (GUIDANC).
Hwee Teoh; Manoela F B Braga; Amparo Casanova; Denis Drouin; Shaun G Goodman; Stewart B Harris; Anatoly Langer; Mary K Tan; Ehud Ur; Andrew T Yan; Bernard Zinman; Lawrence A Leiter
Patient age, ethnicity, medical history, and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets: Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anatoly Langer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Sammy Ali; Shaun G Goodman; Raymond T Yan; Andrzej Budaj; Keith A A Fox; Joel M Gore; David Brieger; Jose López-Sendón; Anatoly Langer; Frans Van de Werf; Ph Gabriel Steg; Andrew T Yan
Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes.
American heart journal 2011;161(5):878-85.
2011: Pamela M Katz; Aurora A Mendelsohn; Shaun G Goodman; Anatoly Langer; Hwee Teoh; Lawrence A Leiter
Use of a treatment optimization algorithm involving statin-ezetimibe combination aids in achievement of guideline-based low-density lipoprotein targets in patients with dyslipidemia at high vascular risk Guideline-based Undertaking to Improve Dyslipidemia Management in Canada (GUIDANC).
The Canadian journal of cardiology 2011;27(2):138-45.
2010: Hwee Teoh; Manoela F B Braga; Amparo Casanova; Denis Drouin; Shaun G Goodman; Stewart B Harris; Anatoly Langer; Mary K Tan; Ehud Ur; Andrew T Yan; Bernard Zinman; Lawrence A Leiter
Patient age, ethnicity, medical history, and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets: Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI).
Diabetes care 2010;33(12):2558-60.
2010: Melissa Rousseau; Raymond T Yan; Mary Tan; Charles J Lefkowitz; Amparo Casanova; David Fitchett; Sanjit S Jolly; Anatoly Langer; Shaun G Goodman; Andrew T Yan
Relation between hemoglobin level and recurrent myocardial ischemia in acute coronary syndromes detected by continuous electrocardiographic monitoring.
The American journal of cardiology 2010;106(10):1417-22.
2010: Adam B Hutchinson-Jaffe; Shaun G Goodman; Raymond T Yan; Ron Wald; Basem Elbarouni; Barry Rose; Kim A Eagle; Christopher C Lai; Carolyn Baer; Anatoly Langer; Andrew T Yan
Comparison of baseline characteristics, management and outcome of patients with non-ST-segment elevation acute coronary syndrome in versus not in clinical trials.
The American journal of cardiology 2010;106(10):1389-96.
2010: Vineet Bhan; Raymond T Yan; Lawrence A Leiter; David Fitchett; Anatoly Langer; Eva Lonn; Mary Tan; Stewart Silagy; Shaun G Goodman; Andrew T Yan
Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients.
The American journal of cardiology 2010;106(9):1270-6.
2010: Kenneth W Mahaffey; Simon T Tonev; Sarah A Spinler; Glenn N Levine; Richard Gallo; John Ducas; Shaun G Goodman; Elliott M Antman; Richard C Becker; Anatoly Langer; Harvey D White; Philip E Aylward; Jacques J Col; James J Ferguson; Robert M Califf
Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
International journal of cardiology 2010;139(2):123-33.
2009: Amit Segev; Paul Fefer; Bradley Strauss; Shlomi Matetzky; Mary Tan; Anatoly Langer; Shaun G Goodman
Outcome of patients with acute coronary syndromes enrolled in clinical trials.
Coronary artery disease 2009;20(7):473-6.
2009: Warren J Cantor; David Fitchett; Bjug Borgundvaag; John Ducas; Michael Heffernan; Eric A Cohen; Laurie J Morrison; Anatoly Langer; Vladimir Dzavik; Shamir R Mehta; Charles Lazzam; Brian Schwartz; Amparo Casanova; Shaun G Goodman
Routine early angioplasty after fibrinolysis for acute myocardial infarction.
The New England journal of medicine 2009;360(26):2705-18.
2009: Alan J Bagnall; Shaun G Goodman; Keith A A Fox; Raymond T Yan; Joel M Gore; Asim N Cheema; thao huynh; Denis Chauret; David Fitchett; Anatoly Langer; Andrew T Yan
Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes.
The American journal of cardiology 2009;103(11):1530-6.
2009: Gustavo Saposnik; Shaun G Goodman; Lawrence A Leiter; Raymond T Yan; David H Fitchett; Neville H Bayer; Amparo Casanova; Anatoly Langer; Andrew T Yan
Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?
Stroke; a journal of cerebral circulation 2009;40(4):1417-24.
2009: Andrew T Yan; Raymond T Yan; thao huynh; Amparo Casanova; F Emilio Raimondo; David Fitchett; Anatoly Langer; Shaun G Goodman
Understanding physicians' risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 Registry.
Archives of internal medicine 2009;169(4):372-8.
2008: Jennifer L Y Tsang; Aurora Mendelsohn; Mary K K Tan; Daniel G Hackam; Lawrence A Leiter; David Fitchett; Peter J Lin; Etienne Grima; Anatoly Langer; Shaun G Goodman
Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy.
The American journal of cardiology 2008;102(9):1142-5.
2008: Salem Alkaabi; Fahad Baslaib; Amparo Casanova; Andrew T Yan; David Fitchett; Aurora Mendelsohn; Jano Y Nikhil; Anatoly Langer; Shaun G Goodman
Clinical implications of a next-day follow-up electrocardiogram in patients with non-ST elevation acute coronary syndromes.
American heart journal 2008;156(4):797-803.
2008: Andrew T Yan; Raymond T Yan; thao huynh; Paul DeYoung; Andrew Weeks; David Fitchett; Anatoly Langer; Shaun G Goodman
Bleeding and outcome in acute coronary syndrome: insights from continuous electrocardiogram monitoring in the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) Trial.
American heart journal 2008;156(4):769-75.
2008: Lawrence A Leiter; Pierre Martineau; Eduardo de Teresa; Csaba Farsang; Allan Gaw; Gianfranco Gensini; Anatoly Langer
How to reach LDL targets quickly in patients with diabetes or metabolic syndrome.
The Journal of family practice 2008;57(10):661-8.
2008: Amit Segev; Bradley Strauss; Mary Tan; Christopher E Buller; Aurora Mendelsohn; Anatoly Langer; Shaun G Goodman
Risk factors and outcome of in-hospital ischemic stroke in patients with non-ST elevation acute coronary syndromes.
International journal of cardiology 2008;129(2):233-7.
2008: David H Fitchett; Shaun G Goodman; Anatoly Langer
Ischemic stroke: a cardiovascular risk equivalent? Lessons learned from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
The Canadian journal of cardiology 2008;24(9):705-8.
2008: Basem Elbarouni; Shaun G Goodman; Raymond T Yan; Amparo Casanova; Abdul Al-Hesayen; Stephen Pearce; David Fitchett; Anatoly Langer; Andrew T Yan
Impact of delayed presentation on management and outcome of non-ST-elevation acute coronary syndromes.
American heart journal 2008;156(2):262-8.
2008: Ki-Dong Lim; Andrew T Yan; Amparo Casanova; Raymond T Yan; Aurora Mendelsohn; Sanjit Jolly; David Fitchett; Anatoly Langer; Shaun G Goodman
Quantitative troponin elevation does not provide incremental prognostic value beyond comprehensive risk stratification in patients with non-ST-segment elevation acute coronary syndromes.
American heart journal 2008;155(4):718-24.
2008: Kenneth W Mahaffey; Qinghong Yang; Karen S Pieper; Elliott M Antman; Harvey D White; Shaun G Goodman; Marc Cohen; Neal S Kleiman; Anatoly Langer; Philip E G Aylward; Jacques J Col; Craig J Reist; James J Ferguson; Robert M Califf
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.
Journal of general internal medicine 2008;23(3):310-6.
2008: Cindy H Lee; Mary Tan; Andrew T Yan; Raymond T Yan; David Fitchett; Etienne Grima; Anatoly Langer; Shaun G Goodman
Use of cardiac catheterization for non-ST-segment elevation acute coronary syndromes according to initial risk: reasons why physicians choose not to refer their patients.
Archives of internal medicine 2008;168(3):291-6.
2008: Manoela B Braga; Anatoly Langer; Lawrence A Leiter
Recommendations for management of dyslipidemia in high cardiovascular risk patients.
Experimental and clinical cardiology 2008;13(2):71-4.
2008: Warren J Cantor; David Fitchett; Bjug Borgundvaag; Michael Heffernan; Eric A Cohen; Laurie J Morrison; John Ducas; Anatoly Langer; Shamir Mehta; Charles Lazzam; Brian Schwartz; Vladimir Dzavik; Shaun G Goodman
Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).
American heart journal 2008;155(1):19-25.
2008: Ram Vijayaraghavan; Andrew T Yan; Mary Tan; David Fitchett; Alina A Georgescu; Quamrul Hassan; Anatoly Langer; Shaun G Goodman
Local hospital vs. core-laboratory interpretation of the admission electrocardiogram in acute coronary syndromes: increased mortality in patients with unrecognized ST-elevation myocardial infarction.
European heart journal 2008;29(1):31-7.
2007: Pierluigi Tricoci; Yuliya Lokhnygina; Lisa G Berdan; Steven R Steinhubl; Dietrich C Gulba; Harvey D White; Neal S Kleiman; Philip E G Aylward; Anatoly Langer; Robert M Califf; James J Ferguson; Elliott M Antman; L Kristin Newby; Robert A Harrington; Shaun G Goodman; Kenneth W Mahaffey
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
Circulation 2007;116(23):2669-77.
2007: Daniel G Hackam; Lawrence A Leiter; Andrew T Yan; Raymond T Yan; Aurora Mendelsohn; Mary Tan; Louis Zavodni; Richard Chen; Jennifer L Tsang; Anjali Kundi; Peter J Lin; David Fitchett; Anatoly Langer; Shaun G Goodman
Missed opportunities for the secondary prevention of cardiovascular disease in Canada.
The Canadian journal of cardiology 2007;23(14):1124-30.
2007: Andrew T Yan; Raymond T Yan; Mary Tan; thao huynh; Kamyar Soghrati; Lawrence J Brunner; Paul DeYoung; David Fitchett; Anatoly Langer; Shaun G Goodman
Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
American heart journal 2007;154(6):1108-15.
2007: Andrew T Yan; Raymond T Yan; Mary Tan; Anthony Fung; Eric A Cohen; David Fitchett; Anatoly Langer; Shaun G Goodman
Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes.
Archives of internal medicine 2007;167(10):1009-16.
2007: Andrew T Yan; Raymond T Yan; Mary Tan; Amparo Casanova; Marino Labinaz; Kumar Sridhar; David Fitchett; Anatoly Langer; Shaun G Goodman
Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better.
European heart journal 2007;28(9):1072-8.
2007: Andrew T Yan; Raymond T Yan; Mary Tan; Mano Senaratne; David Fitchett; Anatoly Langer; Shaun G Goodman
Long-term prognostic value and therapeutic implications of continuous ST-segment monitoring in acute coronary syndrome.
American heart journal 2007;153(4):500-6.
2007: Sanjit Jolly; Mary Tan; Aurora Mendelsohn; David Fitchett; Paul W Armstrong; Anatoly Langer; Shaun G Goodman
Comparison of effectiveness of enoxaparin versus unfractionated heparin to reduce silent and clinically apparent acute myocardial infarction in patients presenting with non-ST-segment elevation acute coronary syndrome.
The American journal of cardiology 2007;99(2):186-8.
2007: Warren J Cantor; Kenneth W Mahaffey; Zhen Huang; Pranab Das; Dietrich C Gulba; Stanislav Glezer; Richard Gallo; John Ducas; Marc Cohen; Elliott M Antman; Anatoly Langer; Neal S Kleiman; Harvey D White; Robert J Chisholm; Robert A Harrington; James J Ferguson; Robert M Califf; Shaun G Goodman
Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;69(1):73-83.
2006: Warren J Cantor; Jason Burnstein; Richard Choi; Michael Heffernan; Vladimir Dzavik; Charles Lazzam; Marko Duic; David Fitchett; Mary Tan; Janet Wawrzyniak; Saleem Kassam; Sanjay Dhingra; Laurie J Morrison; Anatoly Langer; Shaun G Goodman
Transfer for urgent percutaneous coronary intervention early after thrombolysis for ST-elevation myocardial infarction: the TRANSFER-AMI pilot feasibility study.
The Canadian journal of cardiology 2006;22(13):1121-6.
2006: Raymond T Yan; Andrew T Yan; Mary Tan; Darren K McGuire; Lawrence Leiter; David Fitchett; Claude Lauzon; Kevin Lai; Chi-Ming Chow; Anatoly Langer; Shaun G Goodman
Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes.
American heart journal 2006;152(4):676-83.
2006: Daniel G Hackam; Mary K Tan; Peter J Lin; Pravinsagar G Mehta; Shahin Jaffer; Martin Kates; Mona Oh; Etienne Grima; Anatoly Langer; Shaun G Goodman
Supporting a call to action for peripheral artery disease: insights from two prospective clinical registries.
Journal of vascular surgery 2006;44(4):776-81.
2006: Amit Segev; Bradley Strauss; Mary Tan; Aurora Mendelsohn; Kevin Lai; Thomas Ashton; David Fitchett; Etienne Grima; Anatoly Langer; Shaun G Goodman
Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registries).
The American journal of cardiology 2006;98(4):470-3.
2006: David H Fitchett; Lawrence A Leiter; Shaun G Goodman; Anatoly Langer
Lower is better: implications of the Treating to New Targets (TNT) study for Canadian patients.
The Canadian journal of cardiology 2006;22(10):835-9.
2006: Andrew T Yan; Raymond T Yan; Mary Tan; Daniel G Hackam; Kori L Leblanc; Heather Kertland; Jennifer L Tsang; Shahin Jaffer; Martin L Kates; Lawrence A Leiter; David Fitchett; Anatoly Langer; Shaun G Goodman
Contemporary management of dyslipidemia in high-risk patients: targets still not met.
The American journal of medicine 2006;119(8):676-83.
2006: Shaun G Goodman; Yuling Fu; Anatoly Langer; Aiala Barr; Mary Tan; Galen S Wagner; Alejandro Barbagelata; Elena B Sgarbossa; Yochai Birnbaum; Christopher B Granger; Robert M Califf; Frans Van de Werf; Eric J Topol; Paul W Armstrong
The prognostic value of the admission and predischarge electrocardiogram in acute coronary syndromes: the GUSTO-IIb ECG Core Laboratory experience.
American heart journal 2006;152(2):277-84.
2006: Andrew T Yan; Raymond T Yan; Mary Tan; Chi-Ming Chow; David Fitchett; Alina A Georgescu; Quamrul Hassan; Janna Luchansky; Anatoly Langer; Shaun G Goodman
ST-segment depression in non-ST elevation acute coronary syndromes: quantitative analysis may not provide incremental prognostic value beyond comprehensive risk stratification.
American heart journal 2006;152(2):270-6.
2006: David Fitchett; Bjug Borgundvaag; Warren J Cantor; Eric Cohen; Sanjay Dhingra; Stephen E Fremes; Milan Gupta; Michael Heffernan; Heather Kertland; Mansoor Husain; Anatoly Langer; Eric Letovsky; Shaun G Goodman
Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm.
The Canadian journal of cardiology 2006;22(8):663-77.
2006: Shaun G Goodman; Gerardo E Bozovich; Mary Tan; Alfonso Dos Santos; Enrique P Gurfinkel; Marc Cohen; Anatoly Langer
The greatest benefit of enoxaparin over unfractionated heparin in acute coronary syndromes is achieved in patients presenting with ST-segment changes: the Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) Electrocardiogram Core Laboratory Substudy.
American heart journal 2006;151(4):791-7.
2006: Andrew T Yan; Raymond T Yan; Mary Tan; Christian Constance; Claude Lauzon; Jeffrey S Zaltzman; Ron Wald; David Fitchett; Anatoly Langer; Shaun G Goodman
Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromes.
The Canadian journal of cardiology 2006;22(2):115-20.
2006: David Fitchett; Anatoly Langer; Paul W Armstrong; Mary Tan; Aurora Mendelsohn; Shaun G Goodman
Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial.
American heart journal 2006;151(2):373-9.
2006: Raymond T Yan; Andrew T Yan; Mary Tan; Chi-Ming Chow; David Fitchett; Frank L Ervin; James Y M Cha; Anatoly Langer; Shaun G Goodman
Age-related differences in the management and outcome of patients with acute coronary syndromes.
American heart journal 2006;151(2):352-9.
2006: David Fitchett; Amparo Casanova; Shahin Jaffer; Mary Tan; Oksana Kornilova; Shaun G Goodman; Anatoly Langer
Bedtime administration of graded-release diltiazem in patients with inadequate BP control: a tolerability and efficacy study.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2006;6(6):393-400.
2005: Kenneth W Mahaffey; Marc Cohen; Jyotsna Garg; Elliott M Antman; Neal S Kleiman; Shaun G Goodman; Lisa G Berdan; Craig J Reist; Anatoly Langer; Harvey D White; Philip E G Aylward; Jacques J Col; James J Ferguson; Robert M Califf
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.
JAMA : the journal of the American Medical Association 2005;294(20):2594-600.
2005: Amit Segev; Bradley Strauss; Mary Tan; Christian Constance; Anatoly Langer; Shaun G Goodman
Predictors and 1-year outcome of major bleeding in patients with non-ST-elevation acute coronary syndromes: insights from the Canadian Acute Coronary Syndrome Registries.
American heart journal 2005;150(4):690-4.
2005: Andrew T Yan; Raymond T Yan; Mary Tan; Kim A Eagle; Christopher B Granger; Omar H Dabbous; David Fitchett; Etienne Grima; Anatoly Langer; Shaun G Goodman
In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score.
The American journal of cardiology 2005;96(7):913-6.
2005: David Fitchett; Robert C Welsh; Anatoly Langer; Shaun Goodman
Enoxaparin and percutaneous coronary intervention: a Canadian perspective.
The Canadian journal of cardiology 2005;21(6):501-7.
2005: Warren J Cantor; Shaun G Goodman; Christopher P Cannon; Sabina A Murphy; Andrew Charlesworth; Eugene Braunwauld; Anatoly Langer
Early cardiac catheterization is associated with lower mortality only among high-risk patients with ST- and non-ST-elevation acute coronary syndromes: observations from the OPUS-TIMI 16 trial.
American heart journal 2005;149(2):275-83.
2005: David Fitchett; Lawrence A Leiter; Jean-Claude Tardif; Shaun Goodman; Anatoly Langer
Are Canadian guidelines for cholesterol lowering in high-risk patients optimal?
The Canadian journal of cardiology 2005;21(1):85-90.
2004: Daniel G Hackam; Mary K K Tan; George Honos; Lawrence A Leiter; Anatoly Langer; Shaun G Goodman
How does the prognosis of diabetes compare with that of established vascular disease? Insights from the Canadian Vascular Protection (VP) Registry.
American heart journal 2004;148(6):1028-33.
2004: Andrew T Yan; Philip Jong; Raymond T Yan; Mary Tan; David Fitchett; Chi-Ming Chow; Matthew T Roe; Karen S Pieper; Anatoly Langer; Shaun G Goodman
Clinical trial--derived risk model may not generalize to real-world patients with acute coronary syndrome.
American heart journal 2004;148(6):1020-7.
2004: Andrew T Yan; Raymond T Yan; Mary Tan; Chi-Ming Chow; David Fitchett; Eric Stanton; Anatoly Langer; Shaun G Goodman
Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients.
European heart journal 2004;25(22):2006-12.
2004: John L Petersen; Kenneth W Mahaffey; Vic Hasselblad; Elliott M Antman; Marc Cohen; Shaun G Goodman; Anatoly Langer; Michael A Blazing; Anne Le-Moigne-Amrani; James A de Lemos; Christopher C. Nessel; Robert A Harrington; James J Ferguson; Eugene Braunwald; Robert M Califf
Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview.
JAMA : the journal of the American Medical Association 2004;292(1):89-96.
2004: Andrew T Yan; Mary Tan; David Fitchett; Chi-Ming Chow; Ronald A Fowlis; Thomas G McAvinue; Matthew T Roe; eric peterson; Jack V Tu; Anatoly Langer; Shaun G Goodman
One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndromes Registry).
The American journal of cardiology 2004;94(1):25-9.
2003: Anatoly Langer; Christian Constance; J George Fodor; Jiri J Frohlich; Jean Grégoire; David C W Lau; Lawrence A Leiter; G B John Mancini; David Marr; Ruth McPherson; Blair O'Neill; Simon W Rabkin
Statin therapy and the management of acute coronary syndromes.
The Canadian journal of cardiology 2003;19(8):921-7.
2003: Shaun G Goodman; David Fitchett; Paul W Armstrong; Mary Tan; Anatoly Langer
Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide.
Circulation 2003;107(2):238-44.
2002: Shaun G Goodman; Aiala Barr; Anatoly Langer; Galen S Wagner; David Fitchett; Paul W Armstrong; C David Naylor
Development and prognosis of non-Q-wave myocardial infarction in the thrombolytic era.
American heart journal 2002;144(2):243-50.
2002: Douglas S Lee; Shaun Goodman; Deanne M Dean; Jacques Lenis; Patrick Ma; Pierre B Gervais; Anatoly Langer
Randomized comparison of T-type versus L-type calcium-channel blockade on exercise duration in stable angina: results of the Posicor Reduction of Ischemia During Exercise (PRIDE) trial.
American heart journal 2002;144(1):60-7.
2001: Mary Keith; Khursheed N Jeejeebhoy; Anatoly Langer; Regina Kurian; Aiala Barr; B O'Kelly; Michael J Sole
A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure.
The American journal of clinical nutrition 2001;73(2):219-24.
2000: Shaun G Goodman; Aiala Barr; A Sobtchouk; Marc Cohen; GJ Fromell; L Laperrière; C Hill; Anatoly Langer
Low molecular weight heparin decreases rebound ischemia in unstable angina or non-Q-wave myocardial infarction: the Canadian ESSENCE ST segment monitoring substudy.
Journal of the American College of Cardiology 2000;36(5):1507-13.
2000: Shaun G Goodman; Marc Cohen; Frederique Bigonzi; Enrique P Gurfinkel; David Radley; V Le Iouer; GJ Fromell; C Demers; Alexander G G Turpie; Robert M Califf; Keith A A Fox; Anatoly Langer
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events.
Journal of the American College of Cardiology 2000;36(3):693-8.
1999: Philip Jong; Anatoly Langer
Fibrinolytic and antithrombotic regimens in recently completed, ongoing and planned clinical trials in myocardial infarction.
Expert opinion on investigational drugs 1999;8(9):1453-65.
1998: Marc Cohen; C Demers; Enrique P Gurfinkel; Alexander G G Turpie; GJ Fromell; S Goodman; Anatoly Langer; Robert M Califf; Keith A A Fox; J Premmereur; Frederique Bigonzi
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.
The American journal of cardiology 1998;82(5B):19L-24L.
1998: Anatoly Langer; M W Krucoff; PA Klootwijk; Maarten L Simoons; Christopher B Granger; Aiala Barr; Robert M Califf; Paul W Armstrong
Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy.
Journal of the American College of Cardiology 1998;31(4):783-9.
1998: Shaun G Goodman; Anatoly Langer; A M Ross; N M Wildermann; Alejandro Barbagelata; Elena B Sgarbossa; Galen S Wagner; Christopher B Granger; Robert M Califf; Eric J Topol; Maarten L Simoons; Paul W Armstrong
Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators.
Circulation 1998;97(5):444-50.
1997: Marc Cohen; C Demers; Enrique P Gurfinkel; Alexander G G Turpie; GJ Fromell; S Goodman; Anatoly Langer; Robert M Califf; Keith A A Fox; J Premmereur; Frederique Bigonzi
A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
The New England journal of medicine 1997;337(7):447-52.
1997: M R Freeman; D Newman; Paul Dorian; A Barr; Anatoly Langer
Relation of direct assessment of cardiac autonomic function with metaiodobenzylguanidine imaging to heart rate variability in diabetes mellitus.
The American journal of cardiology 1997;80(2):247-50.
1997: J George Fodor; A P Boulet; D Savard; C Nadeau; Karel Rakusan; Arun Chockalingam; Anatoly Langer
The role of diltiazem in treating hypertension and coronary artery disease: new approaches to preventing first events.
The Canadian journal of cardiology 1997;13(5):495-503.
1996: Peter Klootwijk; Anatoly Langer; Simon H Meij; C Green; R F Veldkamp; A M Ross; P W Armstrong; Maarten L Simoons
Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial.
European heart journal 1996;17(5):689-98.
1996: Anatoly Langer; Shaun G Goodman; Eric J Topol; A Charlesworth; Allan Michael Skene; Robert G Wilcox; P W Armstrong
Late assessment of thrombolytic efficacy (LATE) study: prognosis in patients with non-Q wave myocardial infarction. (LATE Study Investigators)
Journal of the American College of Cardiology 1996;27(6):1327-32.
1996: N Singh; D Mironov; P W Armstrong; A M Ross; Anatoly Langer
Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries.
Circulation 1996;93(7):1388-95.
1995: Kevin Wei; Paul Dorian; David Newman; Anatoly Langer
Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus.
Journal of the American College of Cardiology 1995;26(4):859-63.
1995: Anatoly Langer; M W Krucoff; P Klootwijk; R Veldkamp; Maarten L Simoons; C Granger; Robert M Califf; P W Armstrong
Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1995;25(7):1552-7.
1995: Anatoly Langer; M R Freeman; R G Josse; P W Armstrong
Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia.
Journal of the American College of Cardiology 1995;25(3):610-8.
1994: Shaun G Goodman; Anatoly Langer; S S Durica; Gary E Raskob; Philip C Comp; R J Gray; J H Hall; R P Kelley; Tsushung Hua; R J Lee
Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot Study Group.
The American journal of cardiology 1994;74(7):657-61.
1994: Paul Dorian; David Newman; WALTER HUGHES; Anatoly Langer; M Freeman
Torsades de pointes ventricular tachycardia following right pneumonectomy: insights into the relation between right cardiac sympathetic nerve damage, QT intervals, and arrhythmias.
International journal of cardiology 1994;46(3):292-6.
1994: Paul Dorian; Anatoly Langer; C Morgan; L Casella; Louise Harris; P Armstrong
Importance of ST-segment depression as a determinant of ventricular premature complex frequency after thrombolysis for acute myocardial infarction. Tissue Plasminogen Activator: Toronto (TPAT) Study Group.
The American journal of cardiology 1994;74(5):419-23.
1994: Anatoly Langer; P O'Connor
Central modulation of pain perception in patients with silent myocardial ischemia.
The American journal of cardiology 1994;74(2):182-4.
1994: M R Freeman; L de Yang; Anatoly Langer; B Foley; P W Armstrong
Frequency of transient reductions in left ventricular ejection fraction at rest in coronary artery disease.
The American journal of cardiology 1994;74(2):137-43.
1994: Shaun G Goodman; M R Freeman; P W Armstrong; Anatoly Langer
Does ambulatory monitoring contribute to exercise testing and myocardial perfusion scintigraphy in the prediction of the extent of coronary artery disease in stable angina?
The American journal of cardiology 1994;73(11):747-52.
1994: N Singh; Anatoly Langer; M R Freeman; MB Goldstein
Myocardial alterations during hemodialysis: insights from new noninvasive technology.
American journal of nephrology 1994;14(3):173-81.
1993: Mitchell W Krucoff; Cynthia L Green; Anatoly Langer; L J Klootwijk; K M Trollinger; S T Sawchak; N M Wilderman; R F Veldkamp; James E Pope; Maarten L Simoons
Global utilization of streptokinase and tPA for occluded arteries (GUSTO) ECG-monitoring substudy. Study design and technical considerations.
Journal of electrocardiology 1993;26 Suppl():249-55.
1992: Robert A Hegele; M R Freeman; Anatoly Langer; P W Connelly; P W Armstrong
Acute reduction of lipoprotein(a) by tissue-type plasminogen activator.
Circulation 1992;85(6):2034-8.
1992: M R Freeman; Anatoly Langer; R F Wilson; Christopher D Morgan; P W Armstrong
Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo.
Circulation 1992;85(1):150-7.
1991: Anatoly Langer; M R Freeman; R G Josse; G Steiner; P W Armstrong
Detection of silent myocardial ischemia in diabetes mellitus.
The American journal of cardiology 1991;67(13):1073-8.
1991: Anatoly Langer; R F Wilson
Comparison of manual versus automated edge detection for determining degrees of luminal narrowing by quantitative coronary angiography.
The American journal of cardiology 1991;67(9):885-8.
1990: Anatoly Langer; M R Freeman; P W Armstrong
Relation of angiographic detected intracoronary thrombus and silent myocardial ischemia in unstable angina pectoris.
The American journal of cardiology 1990;66(19):1381-2.
1989: Anatoly Langer; M R Freeman; P W Armstrong
ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome.
Journal of the American College of Cardiology 1989;13(7):1495-502.